RxDoctor Payments Data

Jason Calloway, APRN

Psychiatric/Mental Health · Las Vegas, NVNPI 1730728841

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,079 of the $3,501 with a category attached, or 87.9%. It is spread thinly across 22 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,922 and has fallen 85.7% since, to $275 in 2025.

$3,501in general payments, 2019–2025

Across 121 payments — averaging $28.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$792
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$649
  • Johnson & Johnson$641
  • Otsuka America Pharmaceutical, Inc.$266
  • Takeda Pharmaceuticals U.S.A., Inc.$140
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$120
  • plus $893 from 16 others

What the payments were for

  • Travel & lodging$2678%
  • Food & beverage$3,07988%
  • Education$1554%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,501 in reported general payments places this provider in the 85th percentile of 362 psychiatric/mental health providers in Nevada.

See all psychiatric/mental health providers in Nevada

Medicare billing

Part B allowed, 2024
$9,064
Medicare patients
31
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium58$18,172
Doxepin Hcl26$12,329
Lidocaine96$5,677
Oxycodone Hcl137$3,491
Aripiprazole47$3,127
Naloxone Hcl29$2,111
Tizanidine Hcl68$1,880
Morphine Sulfate ErMorphine Sulfate48$1,733
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen46$1,207
Gabapentin64$578
Lidocaine-PrilocaineLidocaine/Prilocaine24$479
Ibuprofen55$475
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$438
Albuterol Sulfate HfaAlbuterol Sulfate13$379
Quetiapine Fumarate36$347

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$13$7521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 362 psychiatric/mental health providers in Nevada.

Other psychiatric/mental health in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →